My hope would be that with a successful CoVid trial that RVX might even get a second BTD and perhaps that would tip the scales to getting the company sold, make investors some money and get all the science into some well funded, competent business hands. I personally think it is appalling that in the midst of a pandemic the alleged business end of RVX has been talking about a CoVid trial for a year yet one has not begun. I think it speaks volumes about business competence when Don tells us the CRO that will be doing the trial has already done 20 such trials, why is RVX management so far back in the que with such promise?  

Further, I think it is also pretty sad that we are coming up to 2 years since the end of BETOnMACE and we still do not know definitively how the follow up will be run or paid for or how it will affect what our investment looks like.